Development of personalized medicine for breast cancer based on elucidation of resistance mechanisms to CDK4/6 inhibitors
Development of personalized medicine for breast cancer based on elucidation of resistance mechanisms to CDK4/6 inhibitors
复制标题
基于CDK4/6抑制剂耐药机制的乳腺癌个体化医疗的开发
DOI：
--
复制
发表时间：
2022
期刊：
影响因子：
--
通讯作者：
Yoshie Kobayashi
中科院分区：
文献类型：
--
作者：
Matoba Keiichiro;Takeda Yusuke;Nagai Yosuke;Sekiguchi Kensuke;Ukichi Rikako;Takahashi Hiroshi;Aizawa Daisuke;Ikegami Masahiro;Tachibana Toshiaki;Kawanami Daiji;Kanazawa Yasushi;Yokota Tamotsu;Utsunomiya Kazunori;Nishimura Rimei;的場 圭一郎;的場 圭一郎;Tetsuya Kimura;木村哲也;Hiroyasu Nishimaki;Yoshie Kobayashi
